Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Quinine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000923 AN001513 Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease Feces Human Inflammatory bowel disease The Broad Institute Abundance
ST000444 AN000695 Preconcentration of organic solutes in urine by bubble bursting Urine Human V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology Arbitrary units
ST001863 AN003020 Analysis of Bxa induced metabolic changes in epithelial cells Cultured cells Human Broad Institute Area under curve
ST001639 AN002681 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham Women's Hospital intensity
ST001236 AN002054 Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part II Blood Human Cancer Broad Institute Log10(Peak Area)
ST001237 AN002055 Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part III Blood Human Cancer Broad Institute Log10(Peak Area)
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST002498 AN004654 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST002536 AN004171 Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma Thyroid Human Cancer Broad Institute of MIT and Harvard peak area
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan Peak area
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan Peak area
ST001708 AN002782 Oxylipin biosynthesis reinforces cellular senescence through a RAS/p53 feedback loop and allows detection of senolysis Blood Mouse Buck Institute for Research on Aging Peak area
ST001749 AN002849 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin - Madison Raw area counts
ST002819 AN004591 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004594 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002088 AN003406 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003410 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST001519 AN002525 Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) Feces Human Broad Institute of MIT and Harvard unitless peak areas
ST001521 AN002533 Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) Blood Human Broad Institute of MIT and Harvard unitless peak areas
  logo